{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:03:03Z","timestamp":1781373783604,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002465","name":"Daejeon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HF23C0074"],"award-info":[{"award-number":["HF23C0074"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.biopha.2024.116250","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T05:54:45Z","timestamp":1707112485000},"page":"116250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Lactobacillus Casei-fermented Amomum Xanthioides Mitigates non-alcoholic fatty liver disease in a high-fat diet mice model"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1037-9133","authenticated-orcid":false,"given":"Seung-Ju","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4371-6239","authenticated-orcid":false,"given":"Yu-Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Gue","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2024.116250_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.06.022","article-title":"Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea","volume":"45","author":"Im","year":"2021","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116250_bib2","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7570\/jomes22021","article-title":"Recent epidemiology and risk factors of nonalcoholic fatty liver disease","volume":"31","author":"Huh","year":"2022","journal-title":"J. Obes. Metab. Syndr."},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116250_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jceh.2020.09.001","article-title":"What are the current pharmacological therapies for nonalcoholic fatty liver disease?","volume":"11","author":"David","year":"2021","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116250_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/dc10-1068","article-title":"Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study","volume":"34","author":"Lewis","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann. Intern Med"},{"issue":"7","key":"10.1016\/j.biopha.2024.116250_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116250_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1756283X09105462","article-title":"The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial","volume":"2","author":"Shields","year":"2009","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116250_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40200-015-0184-8","article-title":"Targeting metabolic disorders by natural products","volume":"14","author":"Tabatabaei-Malazy","year":"2015","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.biopha.2024.116250_bib12","doi-asserted-by":"crossref","first-page":"5936402","DOI":"10.1155\/2016\/5936402","article-title":"Herbal medicines for treating metabolic syndrome: a systematic review of randomized controlled trials","volume":"2016","author":"Jang","year":"2016","journal-title":"Evid. Based Complement Altern. Med"},{"issue":"4","key":"10.1016\/j.biopha.2024.116250_bib13","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/nu7042440","article-title":"Hepatoprotective effect of herb formula KIOM2012H against nonalcoholic fatty liver disease","volume":"7","author":"Park","year":"2015","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/cells11010023","article-title":"Cynanchum atratum alleviates non-alcoholic fatty liver by balancing lipogenesis and fatty acid oxidation in a high-fat, high-fructose diet mice model","volume":"11","author":"Wang","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1017\/S0960428611000436","article-title":"A revision of Amomum (Zingiberaceae) in cambodia, laos and vietnam","volume":"69","author":"Lamxay","year":"2012","journal-title":"Edinb. J. Bot."},{"issue":"2","key":"10.1016\/j.biopha.2024.116250_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jep.2011.03.026","article-title":"An herbal fruit, Amomum xanthoides, ameliorates thioacetamide-induced hepatic fibrosis in rat via antioxidative system","volume":"135","author":"Wang","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116250_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.fct.2018.05.051","article-title":"Phytochemicals, pharmacology, clinical application, patents, and products of Amomi fructus","volume":"119","author":"Suo","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2024.116250_bib19","doi-asserted-by":"crossref","first-page":"6014380","DOI":"10.1155\/2016\/6014380","article-title":"Ethyl acetate fraction of amomum xanthioides exerts antihepatofibrotic actions via the regulation of fibrogenic cytokines in a dimethylnitrosamine-induced rat model","volume":"2016","author":"Lee","year":"2016","journal-title":"Evid. Based Complement Altern. Med"},{"key":"10.1016\/j.biopha.2024.116250_bib20","doi-asserted-by":"crossref","first-page":"14531","DOI":"10.1038\/srep14531","article-title":"Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines","volume":"5","author":"Kim","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2024.116250_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/nu12082433","article-title":"Ethyl acetate fraction of amomum xanthioides ameliorates nonalcoholic fatty liver disease in a high-fat diet mouse model","volume":"12","author":"Im","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.biopha.2024.116250_bib22","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3390\/antiox11112254","article-title":"Bacillus subtilis-fermented amomum xanthioides ameliorates metabolic-syndrome-like pathological conditions in long-term HFHFD-fed mice","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2024.116250_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.foodres.2015.12.026","article-title":"Fermentation, a feasible strategy for enhancing bioactivity of herbal medicines","volume":"81","author":"Hussain","year":"2016","journal-title":"Food Res. Int."},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jpbs.JPBS_175_19","article-title":"Preparation of medicinal plants: basic extraction and fractionation procedures for experimental purposes","volume":"12","author":"Abubakar","year":"2020","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.biopha.2024.116250_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2020.109264","article-title":"Effect of solid-state fermentation with Lactobacillus casei on the nutritional value, isoflavones, phenolic acids and antioxidant activity of whole soybean flour","volume":"125","author":"Li","year":"2020","journal-title":"Lwt"},{"key":"10.1016\/j.biopha.2024.116250_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105139","article-title":"Lactobacillus casei-fermented blueberry pomace ameliorates colonic barrier function in high fat diet mice through MAPK-NF-\u03baB-MLCK signaling pathway","volume":"95","author":"Cheng","year":"2022","journal-title":"J. Funct. Foods"},{"issue":"6","key":"10.1016\/j.biopha.2024.116250_bib27","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1074\/jbc.M114.604421","article-title":"Metformin activates AMP-activated protein kinase by promoting formation of the alphabetagamma heterotrimeric complex","volume":"290","author":"Meng","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2024.116250_bib28","article-title":"Bacillus subtilis-fermented amomum xanthioides ameliorates metabolic-syndrome-like pathological conditions in long-term HFHFD-fed mice","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxid. (Basel)"},{"issue":"10","key":"10.1016\/j.biopha.2024.116250_bib29","article-title":"Comparative analysis of the antioxidative and hepatoprotective activities of dimethyl diphenyl bicarboxylate in four animal models of hepatic injury","volume":"10","author":"Wang","year":"2021","journal-title":"Antioxid. (Basel)"},{"issue":"6","key":"10.1016\/j.biopha.2024.116250_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/md21060360","article-title":"Antioxidant peptides from monkfish swim bladders: ameliorating NAFLD in vitro by suppressing lipid accumulation and oxidative stress via regulating AMPK\/Nrf2 pathway","volume":"21","author":"Wu","year":"2023","journal-title":"Mar. Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2024.116250_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/egh.09.32","article-title":"Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal","volume":"3","author":"Alkhouri","year":"2009","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116250_bib32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2007.06.020","article-title":"Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study","volume":"47","author":"Zelber-Sagi","year":"2007","journal-title":"J. Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.116250_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.14360","article-title":"The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management","volume":"40","author":"Berna","year":"2020","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog. Lipid Res."},{"issue":"16","key":"10.1016\/j.biopha.2024.116250_bib35","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3748\/wjg.14.2474","article-title":"Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment","volume":"14","author":"Schreuder","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2024.116250_bib37","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/jn\/134.6.1400","article-title":"Individual serum triglyceride responses to high-fat and low-fat diets differ in men with modest and severe hypertriglyceridemia","volume":"134","author":"Jacobs","year":"2004","journal-title":"J. Nutr."},{"issue":"10","key":"10.1016\/j.biopha.2024.116250_bib38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.ijo.0801440","article-title":"Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin","volume":"24","author":"Pieke","year":"2000","journal-title":"Int. J. Obes."},{"issue":"13","key":"10.1016\/j.biopha.2024.116250_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137280","article-title":"Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease","volume":"23","author":"Ramanathan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.biopha.2024.116250_bib40","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116250_bib41","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/liv.14309","article-title":"Dietary fatty acid oxidation is decreased in non\u2010alcoholic fatty liver disease: a palmitate breath test study","volume":"40","author":"Naguib","year":"2020","journal-title":"Liver Int."},{"issue":"20","key":"10.1016\/j.biopha.2024.116250_bib42","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1042\/BCJ20210071","article-title":"SREBP-1c and lipogenesis in the liver: an update","volume":"478","author":"Ferr\u00e9","year":"2021","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.biopha.2024.116250_bib43","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1159\/000358720","article-title":"SREBP-1c gene silencing can decrease lipid deposits in bovine hepatocytes cultured in vitro","volume":"33","author":"Deng","year":"2014","journal-title":"Cell Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12944-019-1026-3","article-title":"Influences of sterol regulatory element binding protein-1c silencing on glucose production in HepG2 cells treated with free fatty acid","volume":"18","author":"Bai","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2024.116250_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.164808","article-title":"Investigation of nephrotoxicity on mice exposed to polystyrene nanoplastics and the potential amelioration effects of DHA-enriched phosphatidylserine","volume":"892","author":"Tang","year":"2023","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.biopha.2024.116250_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.procbio.2023.11.005","article-title":"Non-targeted metabolomics reveals a modulatory effect of DHA-enriched phosphatidylserine in high fat-diet induced non-alcoholic fatty liver disease in mice","volume":"135","author":"Zhang","year":"2023","journal-title":"Process Biochem."},{"issue":"7","key":"10.1016\/j.biopha.2024.116250_bib47","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI29044","article-title":"AMP-activated protein kinase signaling in metabolic regulation","volume":"116","author":"Long","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biopha.2024.116250_bib48","article-title":"PPAR alpha as a metabolic modulator of the liver: role in the pathogenesis of nonalcoholic steatohepatitis (NASH)","volume":"11","author":"Todisco","year":"2022","journal-title":"Biol. (Basel)"},{"issue":"7","key":"10.1016\/j.biopha.2024.116250_bib49","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.biopha.2024.116250_bib50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator\u2212 activated receptor\u2212 \u03b1 and\u2212 \u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.biopha.2024.116250_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41419-020-02811-4","article-title":"The critical role of PPAR\u03b1 in the binary switch between life and death induced by endoplasmic reticulum stress","volume":"11","author":"Xu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"Suppl 4","key":"10.1016\/j.biopha.2024.116250_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of NAFLD\/NASH","volume":"28","author":"Hashimoto","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116250_bib53","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116250_bib54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/flgastro-2019-101235","article-title":"NAFLD: a multisystem disease that requires a multidisciplinary approach","volume":"10","author":"Danford","year":"2019","journal-title":"Frontline Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib55","first-page":"45","article-title":"Endoplasmic reticulum stress and unfolded protein response pathways: potential for treating age-related retinal degeneration","volume":"7","author":"Haeri","year":"2012","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.biopha.2024.116250_bib56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2024.116250_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2024.116250_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708959","article-title":"Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression","volume":"12","author":"Fontes-Cal","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116250_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10238-015-0347-4","article-title":"Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients","volume":"16","author":"Paredes-Turrubiarte","year":"2016","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.biopha.2024.116250_bib60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00508-018-1348-6","article-title":"Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease","volume":"130","author":"Zhang","year":"2018","journal-title":"Wien. Klin. Wochenschr."},{"issue":"4","key":"10.1016\/j.biopha.2024.116250_bib61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jgg.2021.09.009","article-title":"Tumor necrosis factor-\u03b1 signaling in nonalcoholic steatohepatitis and targeted therapies","volume":"49","author":"Lu","year":"2022","journal-title":"J. Genet. Genom."},{"issue":"5","key":"10.1016\/j.biopha.2024.116250_bib62","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-inflammatory effects of metformin irrespective of diabetes status","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.116250_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/nu14020324","article-title":"Centenarian-sourced lactobacillus casei combined with dietary fiber complex ameliorates brain and gut function in aged mice","volume":"14","author":"Ren","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.116250_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.574422","article-title":"Antagonistic mechanism of metabolites produced by lactobacillus casei on lysis of enterohemorrhagic Escherichia coli","volume":"11","author":"Aditya","year":"2020","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.biopha.2024.116250_bib65","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1080\/19490976.2020.1712984","article-title":"Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome","volume":"11","author":"Lee","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2024.116250_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5487659","article-title":"Protective role of probiotic supplements in hepatic steatosis: a rat model study","volume":"2020","author":"Azarang","year":"2020","journal-title":"BioMed. Res. Int."},{"issue":"12","key":"10.1016\/j.biopha.2024.116250_bib67","doi-asserted-by":"crossref","first-page":"G911","DOI":"10.1152\/ajpgi.00225.2013","article-title":"Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model","volume":"305","author":"Okubo","year":"2013","journal-title":"Am. J. Physiol. - Gastrointest. Liver Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116250_bib68","article-title":"Improvement of bioavailability of bioactive compounds of medicinal herbs by drying and fermentation with Lactobacillus plantarum","volume":"9","author":"Dogan","year":"2019","journal-title":"Funct. Foods Health Dis."},{"issue":"5","key":"10.1016\/j.biopha.2024.116250_bib69","first-page":"547","article-title":"Total polyphenol contents, flavonoid contents, and antioxidant activity of roasted-flaxseed extracts based on lactic-acid bacteria fermentation","volume":"28","author":"Park","year":"2018","journal-title":"J. Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.116250_bib70","article-title":"Total phenolic and total flavonoid content, individual phenolic compounds and antioxidant activity in sweet rowanberry cultivars","volume":"12","author":"Orsavova","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"11","key":"10.1016\/j.biopha.2024.116250_bib71","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mnfr.201400243","article-title":"Microbial catabolism of procyanidins by human gut microbiota","volume":"58","author":"Ou","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116250_bib72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41702-020-0057-8","article-title":"Activity of catechins and their applications","volume":"4","author":"Bae","year":"2020","journal-title":"Biomed. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116250_bib73","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/ijmm.2013.1503","article-title":"Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study","volume":"32","author":"Sakata","year":"2013","journal-title":"Int. J. Mol. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:44:36Z","timestamp":1760103876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224001318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":73,"alternative-id":["S0753332224001318"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116250","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactobacillus Casei-fermented Amomum Xanthioides Mitigates non-alcoholic fatty liver disease in a high-fat diet mice model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116250"}}